Lars Verschuren

Medicine · Health Sciences

36h-index5.3kcitations121works4.92yr avg
OpenAlex↗ORCID↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Liver Disease Diagnosis and Treatment(40), Adipose Tissue and Metabolism(14), Peroxisome Proliferator-Activated Receptors(13), Adipokines, Inflammation, and Metabolic Diseases(12), Cholesterol and Lipid Metabolism(10)

Publications120 total

Review for "Efsubaglutide Alfa Attenuates Metabolic Dysfunction-associated Steatohepatitis in Mice with Improvements in SHG-derived Fibrosis Features"
2026
Review for "Efsubaglutide Alfa Attenuates Metabolic Dysfunction-associated Steatohepatitis in Mice with Improvements in SHG-derived Fibrosis Features"
2026
Divergent regulation of cellular cholesterol metabolism by seaweed-derived fucosterol and saringosterol
Frontiers in Marine Science·2025Open Access
Anabolic Effects of Salbutamol Are Lost Upon Immobilization
Journal of Cachexia Sarcopenia and Muscle·2025Open Access
Review for "Efsubaglutide Alfa Attenuates Metabolic Dysfunction-associated Steatohepatitis in Mice with Improvements in SHG-derived Fibrosis Features"
2025
In vitro muscle contraction: A technical review on electrical pulse stimulation in C2C12 cells
Experimental Physiology·2025· 2 citedOpen Access
Biomarkers of Metabolism and Inflammation in Individuals with Obesity and Normal Weight: A Comparative Analysis Exploring Sex Differences
International Journal of Molecular Sciences·2025· 4 citedOpen Access
Prognostic Value of the <scp>TLM3</scp> Biomarker Panel for Early Fibrosis Development in <scp>MASLD</scp> Within the General Population
Liver International·2025· 1 citedOpen Access
Fibrogenic Gene Signature as Early Prediction for the Efficacy of Pharmacological Interventions for <scp>MASH</scp> ‐Associated Fibrosis
The FASEB Journal·2025· 2 citedOpen Access
Improved Translational Relevance of In Vitro Fibrosis Models by Integrating IOX2-Mediated Hypoxia-Mimicking Pathways
Biomedicines·2025Open Access
Blood-based biomarkers for early frailty are sex-specific: validation of a combined in silico prediction and data-driven approach
GeroScience·2024· 3 citedOpen Access
Gastrointestinal complaints after Roux-en-Y gastric bypass surgery. Impact of microbiota and its metabolites
Heliyon·2024· 3 citedOpen Access
Therapeutic effects of <scp>FGF21</scp> mimetic <scp>bFKB1</scp> on <scp>MASH</scp> and atherosclerosis in Ldlr−/−.Leiden mice
The FASEB Journal·2024· 3 citedOpen Access
Identifying patient subgroups in MASLD and MASH-associated fibrosis: molecular profiles and implications for drug development
Scientific Reports·2024· 4 citedOpen Access
Integrating text mining with network models for successful target identification: in vitro validation in MASH-induced liver fibrosis
Frontiers in Pharmacology·2024· 4 citedOpen Access
Metabolic dysfunction-associated steatotic liver disease is associated with effects on cerebral perfusion and white matter integrity
Heliyon·2024· 3 citedOpen Access
WED-209 Development of a novel non-invasive biomarker panel for hepatic fibrosis in MASLD
Journal of Hepatology·2024
Development of a novel non-invasive biomarker panel for hepatic fibrosis in MASLD
Nature Communications·2024· 45 citedOpen Access
Supplementation of Seaweed Extracts to the Diet Reduces Symptoms of Alzheimer’s Disease in the APPswePS1ΔE9 Mouse Model
Nutrients·2024· 11 citedOpen Access
Seven robust and easy to obtain biomarkers to measure acute stress
Brain Behavior & Immunity - Health·2024· 4 citedOpen Access
page 1 of 6Next →

Frequent Co-authors

Robert Kleemann(38), Teake Kooistra(21), Martien P. M. Caspers(13), Martine C. Morrison(12), P. Hans(12), Peter Y. Wielinga(12), Anita M. van den Hoek(11), Kanita Salic(10), Ben van Ommen(7), Karin Toet(7), Aswin Menke(7), Wim van Duyvenvoorde(6), Elsbet Pieterman(6), Roeland Hanemaaijer(6), Jaap Keijer(5), Eveline Gart(4), Susanne Zadelaar(4), Jitske de Vries-van der Weij(4), J. Lindeman(4), J. Wouter Jukema(4)